Journey Medical Corporation
DERM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $56,134 | $79,181 | $73,669 | $63,134 |
| % Growth | -29.1% | 7.5% | 16.7% | – |
| Cost of Goods Sold | $20,879 | $26,660 | $30,775 | $32,084 |
| Gross Profit | $35,255 | $52,521 | $42,894 | $31,050 |
| % Margin | 62.8% | 66.3% | 58.2% | 49.2% |
| R&D Expenses | $9,857 | $7,541 | $10,943 | $16,558 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $40,204 | $43,910 | $59,468 | $39,833 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$1,129 | $3,143 | $0 | $9,540 |
| Operating Expenses | $48,932 | $54,594 | $70,411 | $65,931 |
| Operating Income | -$13,677 | -$2,073 | -$27,517 | -$34,881 |
| % Margin | -24.4% | -2.6% | -37.4% | -55.2% |
| Other Income/Exp. Net | -$934 | -$1,559 | -$2,048 | -$7,479 |
| Pre-Tax Income | -$14,611 | -$3,632 | -$29,565 | -$42,360 |
| Tax Expense | $61 | $221 | $63 | $1,634 |
| Net Income | -$14,672 | -$3,853 | -$29,628 | -$43,994 |
| % Margin | -26.1% | -4.9% | -40.2% | -69.7% |
| EPS | -0.72 | -0.21 | -1.69 | -2.54 |
| % Growth | -242.9% | 87.6% | 33.5% | – |
| EPS Diluted | -0.72 | -0.21 | -1.69 | -2.54 |
| Weighted Avg Shares Out | 20,431 | 18,232 | 17,531 | 17,316 |
| Weighted Avg Shares Out Dil | 20,431 | 18,232 | 17,531 | 17,316 |
| Supplemental Information | – | – | – | – |
| Interest Income | $757 | $322 | $60 | $2 |
| Interest Expense | $2,700 | $1,698 | $2,019 | $7,034 |
| Depreciation & Amortization | $3,515 | $3,855 | $4,365 | $2,560 |
| EBITDA | -$8,396 | $1,921 | -$23,181 | -$32,766 |
| % Margin | -15% | 2.4% | -31.5% | -51.9% |